Cargando…
Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still’s disease: when dosage matters in overcoming secondary therapy resistance
Macrophage activation syndrome (MAS) is a severe, potentially fatal complication of rheumatic diseases. This case demonstrates the significant challenges and therapeutic considerations in adult-onset Still’s disease (AOSD) complicated with MAS at initial presentation, which will be discussed. MAS in...
Autores principales: | Ajeganova, Sofia, De Becker, Ann, Schots, Rik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692351/ https://www.ncbi.nlm.nih.gov/pubmed/33281955 http://dx.doi.org/10.1177/1759720X20974858 |
Ejemplares similares
-
Macrophage Activation Syndrome Associated with Adult-Onset Still's Disease Successfully Treated with Anakinra
por: Kumar, Aswini, et al.
Publicado: (2016) -
Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review
por: Ortiz-Sanjuán, Francisco, et al.
Publicado: (2015) -
Anakinra Hepatotoxicity in a Patient With Adult-Onset Still's Disease
por: Ahmed, Osman, et al.
Publicado: (2015) -
Pulmonary Arterial Hypertension in Adult-Onset Still's Disease: Rapid Response to Anakinra
por: Campos, Marc, et al.
Publicado: (2012) -
Anakinra in children and adults with Still’s disease
por: Vastert, Sebastiaan J, et al.
Publicado: (2019)